0001641241-16-000003.txt : 20161116 0001641241-16-000003.hdr.sgml : 20161116 20161116125816 ACCESSION NUMBER: 0001641241-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161116 DATE AS OF CHANGE: 20161116 EFFECTIVENESS DATE: 20161116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyrus Biotechnology, Inc. CENTRAL INDEX KEY: 0001641241 IRS NUMBER: 471015686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-274602 FILM NUMBER: 162001929 BUSINESS ADDRESS: STREET 1: 1201 BOYLSTON AVE. STREET 2: UNIT 417 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 6178182334 MAIL ADDRESS: STREET 1: 1201 BOYLSTON AVE. STREET 2: UNIT 417 CITY: SEATTLE STATE: WA ZIP: 98101 D 1 primary_doc.xml X0707 D LIVE 0001641241 Cyrus Biotechnology, Inc. 500 Yale Avenue North SEATTLE WA WASHINGTON 98109 206-258-6561 DELAWARE None None Corporation true 2014 Nivon Lucas 500 Yale Ave N Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Yifan Song 500 Yale Ave N Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Javier Castellanos 500 Yale Ave N Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false 2016-11-07 false true true Debt is convertible, under certain circumstances, into issuer equity. false 0 500000 490000 10000 false 14 0 0 0 false Cyrus Biotechnology, Inc. /s/ Lucas Nivon Lucas Nivon CEO 2016-11-16